My First Clinical Rotation As A Nursing Student

Alzheimer disease (AD) is the most common cause of dementia in the elderly, accounting for 65–70% of all cases (Jellinger, Janetzky, Attems, & Kienzl, 2008). The other dementias are of the Parkinson 's group, the fronto-temporal group and the vascular group. The total worldwide yearly costs for the treatment and care of patients suffering from dementia are estimated to be around 250 billion US dollars. The lifetime risk for AD between the ages of 65 and 100 is 33% for men and 45% for women with an annual increase of 1–2% in the seventh decade to almost 60% in the 10th decade with doubling every 5 years (Jellinger et al., 2008). AD is incurable, and thus represents a major public health problem. AD represents a challenge to humanity due to its relatively recent discovery, progressive nature of the illness, and complex diagnosis.

The following databases PsycINFO, MEDLINE and CINAHL will be used, and the keywords utilized for the search were Patient, Dementia, behavioral therapy, the older patient, and Long-term care facility. MeSH terms: Dementia patient with disruptive behavior, Long term care facility, disruptive behavior, behavior management therapy. No mesh terms: Alzheimer’s disease, geriatric, long-term care, pharmacological and non-pharmacological studies also focused broadly on disruptive behavior among Long term care facility residents.

Nearly 135 million people worldwide will be impacted by dementia by 2050 (Robinson, Tang, Taylor,. 2015). Dementia is not a disease, it is an overall term that describes a wide range of symptoms associated with the decline in memory and thinking skills. Dementia is a progressive illness that results in the loss of one’s sense of self (Burns, Byrne, Ballard, Holmes, 2002). The two most common forms of dementia are Alzheimer’s disease and Vascular dementia. Dementia is progressive and people with dementia experience complications with short-term memory, keeping track of personal items, paying bills, taking care of themselves and daily tasks (Haigh, Mytton, 2016). Due to the rising number of individuals developing dementia, it is causing major challenges in the healthcare systems and society (Angermeter, Luck, Then, Riedel-Heller, 2016). Utilizing psychotropic medications are often ineffective or harmful to the individual, therefore, many patients decide to utilize sensory therapy as a form of treatment instead (Livingston, Kelly olmes, et al., 2014). Caregivers of individuals with dementia can also experience health consequences related to caregiving at the end of life. Spousal caregivers are 40.5% higher odds of experiencing frailty as a result of caregiving (Carr, Dassel, 2017). Dementia does not only affect the individual, it affects those around them, society, and the healthcare system.

Dementia is an umbrella term used to explain the gradual decline in multiple areas of functions, which includes thinking, perception, communication, memory, languages, reasoning, and the ability to function (Harrison-Dening 2013). Worldwide, 47.5 million people have dementia and there are 7.7 million new cases every year. Alzheimer's disease is the most common cause of dementia and may contribute to 60–70% of cases. (Alzheimer's society 2014). The complexity of dementia presents a number of behavioural challenges to those who live with dementia and their care providers. Aggressive behaviour seems to be one of the most prevalent challenging behaviours in the different stages of dementia (Weitzel et al 2011). As acute care

The term ‘dementia’ is used to describe a syndrome associated with an ongoing decline of the brain and its abilities. This includes problems with memory loss, thinking speed, mental agility, language, understanding, and judgment. People with dementia can become apathetic or uninterested in their usual activities, and have problems controlling their emotion. They also fine social situation challenging, lose interest in socialising and aspect of their personality may change. The majority of people who are diagnosed with dementia have either Alzheimer’s disease or vascular dementia, or a combination of the two. (Source 1) As the disease progresses, the person experiencing dementia becomes more vulnerable and their needs often complex; which requires appropriate care and management (Kitwood, 1997).this leads me to the next distinctive feature of patients with dementia.

Globally, the World Health Organisation reports there are approximately 47.5 million people who have been diagnosed with a form of dementia and there are 7.7 million new cases each year. The number of people effected internationally is estimated to triple by 2050 to

We carried out an extensive review of the literature on non-pharmacological treatments for dementia using Medline and other related searches, but this is not intended to be a formal systematic review.

Dementia can be defined as a decline in mental ability severe enough to interfere with daily life (alz.org). More than often, individuals affected by dementia are over the age of 65. In the United States, there are more than three million cases of dementia each year. According to World Health Organization, the number of people living with dementia is currently estimated at 47.5 million worldwide and is expected to increase to 75.6 million by 2030 (World Health Organization 2015). Dementia is caused by physical modifications in the brain and is known for loss of memory and mental abilities. It’s a progressive disease which means it gets worse over time. If diagnosed early on, the quality of life for people with dementia as well as their family members can be significantly improved. There are many different types of dementias although some are far more reciprocal than others. One of the most common types of dementia is Alzheimer’s disease. Other few types of dementias are “Vascular dementia, Mixed dementia, Parkinson 's disease and Frontotemporal dementia (Krishnan, D. S)”. All of the various forms of dementia tend to have similar symptoms which consequently makes it hard to determine the type of dementia a patient may be suffering from.

By 2015, it is estimated that there will be a number of 850,000 dementia sufferers in the UK and about 225,000 people develop dementia every year in which it is roughly about one person in every three minutes. It is predicted that the number of people with dementia will exceed 2 million in 2050 if preventative measures are not taken. In brief, dementia can be described as a persistent and progressive loss of mental ability due to brain diseases or injuries in which the symptoms can be recognized by memory disorders, perception and personality changes and also impairments of body functions. Alzheimer is the most common type of dementia which contributes about 62% of the cause of dementia and had become a global prevalence disease. By 2015, it

Alzheimer’s disease is a complex illness that affects the brain tissue directly and undergoes gradual memory and behavioral changes which makes it difficult to diagnose. It is known to be the most common form of dementia and is irreversible. Over four million older Americans have Alzheimer’s, and that number is expected to triple in the next twenty years as more people live into their eighties and nineties. (Johnson, 1989). There is still no cure for Alzheimer’s but throughout the past few years a lot of progress has been made.

According to the Alzheimer’s Disease International (ADI), dementia is one of the most prevalent disorders found among

One of the most prominent and perhaps most feared condition associated with aging is dementia. The family of disorders can cause individuals to lose their mind, reducing one from being a complex, thinking, feeling human being to being confused and vegetative, unable to recognize their loved ones. Serious dementia affects nearly 37 million people globally, but predictions of how those numbers will change over the next few decades are conflicting (textbook). Although we know dementia as to do with damage to nerve cells in the brain, there are ongoing studies looking at correlations between other health issues and these types of diseases.

Psychotropic medications are approved by the US Food and Drug Administration (FDA) primarily for the treatment of psychosis and mood disturbances associated with schizophrenia or bipolar disorders (Grunier, 2008). Despite FDA black box warnings related to the “off-label” use of these medications in the dementia population, a survey conducted by the Office of Inspector General in 2011 found that 86% to 95% of nursing home residents received these medications for other indications, such as managing behavioral disturbances associated with dementia (Chiu, 2015). It is the overuse and misuse of psychotropic medications, in particular as a strategy to subdue residents, that has designated these drugs to be labeled

Dementia is an extremely common disease among the elderly, with 4 million Americans currently suffering from the Alzheimer’s type alone. Figures show that 3% of people between the ages of 65-74 suffer from the disease, rapidly increasing to 19% for the 75-84 age bracket, and as high as 47% for the over 85s. Therefore, it is easy to see why Dementia is such a large part of many people’s lives, whether they are suffering from the condition themselves, or have an elderly relative who requires full time care just to undertake simple day to day tasks. The disease can be extremely traumatic for the patient and their families, as the person, who may have been extremely lively and bright throughout their

Alzheimer’s disease is the most common form of progressive dementia currently affecting 5.3 million Americans. Of the 5.3 million, 5.1 million people are the elderly population with two-thirds of those affected being women. There is no treatment available to cure dementia but measures can be taken to sustain the quality of life. Dementia not only affects the patients directly, but also family members and caregivers as well. Family members deal with patient’s memory loss, changes in personality and also have to take care of the ill patients financially. According to WHO, the cost of dementia in 2010 worldwide was estimated to be $604 billion dollars. Apart from the economic pressure, family members also deal with the physical and emotional pressures that come with dementia.